These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1319909)

  • 1. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13).
    Rompré PP; Bauco P; Gratton A
    Eur J Pharmacol; 1992 Feb; 211(3):295-303. PubMed ID: 1319909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward.
    Rompré PP; Gratton A
    Brain Res; 1993 Jul; 616(1-2):154-62. PubMed ID: 8358607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward.
    Rompré PP; Boye SM
    Eur J Pharmacol; 1993 Mar; 232(2-3):299-303. PubMed ID: 8467866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward.
    Rompré PP
    Peptides; 1995; 16(8):1417-20. PubMed ID: 8745052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons.
    Piccart E; Courtney NA; Branch SY; Ford CP; Beckstead MJ
    J Neurosci; 2015 Aug; 35(31):11144-52. PubMed ID: 26245975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of mesencephalic injections of neurotensin(1-13) and neuromedin N on brain electrical self-stimulation.
    Rompré PP; Gratton A
    Peptides; 1992; 13(4):713-9. PubMed ID: 1437713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neurotensin receptors in the prefrontal cortex stimulates midbrain dopamine cell firing.
    Rompré PP; Boye SM; Moisan J
    Eur J Pharmacol; 1998 Jan; 341(2-3):169-72. PubMed ID: 9543236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neurotensin receptor activation on brain stimulation reward in Fischer 344 and Lewis rats.
    Bauco P; Rompré PP
    Eur J Pharmacol; 2001 Nov; 432(1):57-61. PubMed ID: 11734188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin: a new 'reward peptide'.
    Glimcher PW; Margolin DH; Giovino AA; Hoebel BG
    Brain Res; 1984 Jan; 291(1):119-24. PubMed ID: 6320951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons.
    Nalivaiko E; Michaud JC; Soubrié P; Le Fur G
    Neuroscience; 1998 Oct; 86(3):799-811. PubMed ID: 9692718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
    Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
    Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing.
    Fatigati MD; Anderson RM; Rompré P
    Brain Res; 2000 Sep; 876(1-2):196-200. PubMed ID: 10973609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of conditioned and unconditioned stress on the neurotensin content of dopamine cell body groups of the ventral mesencephalon.
    Kilts CD; Coco ML; Ely TD; Bissette G; Nemeroff CB
    Ann N Y Acad Sci; 1992; 668():266-76. PubMed ID: 1361117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin and the mesocorticolimbic dopamine system.
    Bissette G; Nemeroff CB
    Ann N Y Acad Sci; 1988; 537():397-404. PubMed ID: 2849357
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotensin in the ventromedial mesencephalon of the rat: anatomical and functional considerations.
    Kalivas PW
    J Comp Neurol; 1984 Jul; 226(4):495-507. PubMed ID: 6086729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.
    Dilts RP; Kalivas PW
    Brain Res; 1989 May; 488(1-2):311-27. PubMed ID: 2545303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.
    Herve D; Tassin JP; Studler JM; Dana C; Kitabgi P; Vincent JP; Glowinski J; Rostene W
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6203-7. PubMed ID: 3016745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla.
    Urban MO; Gebhart GF
    J Neurophysiol; 1997 Sep; 78(3):1550-62. PubMed ID: 9310442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neurotensin on midbrain dopamine neurons: are they mediated by formation of a neurotensin-dopamine complex?
    Shi WX; Bunney BS
    Synapse; 1991 Nov; 9(3):157-64. PubMed ID: 1776128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.